International Clinical Trial: A Single Dose, Randomized, Open-label, Two-treatment, Three-period, Three-sequence, Partial Replicate Crossover Bioequivalence Study of Generic Edoxaban 60 mg Film-coated Tablets and Reference Product (Lixiana) in Healthy Thai Volunteers under Fasting Conditions

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260417001) titled 'A Single Dose, Randomized, Open-label, Two-treatment, Three-period, Three-sequence, Partial Replicate Crossover Bioequivalence Study of Generic Edoxaban 60 mg Film-coated Tablets and Reference Product (Lixiana) in Healthy Thai Volunteers under Fasting Conditions' on April 17.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: International Bio Service Co., Ltd.

Condition: Bioequivalence study in healthy Thai male volunteers Edoxaban 60 mg Film-coated Tablets and Reference Product (Lixiana) in Healthy Thai Volunteers under Fasting Conditions Edoxaban 60 mg Film-coated Tablets and Reference ...